The Role of Dasatinib in Targeted Therapy for Philadelphia Chromosome-Positive Leukemias
Amongst thrombopoietin receptor agonists, Avatrombopag tablets 20mg, Cabozantinib tablets 20mg, Eltrombopag 25mg, and Eltrombopag 50mg tablets attract attention for their use in chronic ITP and liver disease-associated thrombocytopenia. For ALK-positive NSCLC, Crizotinib capsules use first-line options, while Finerenone 10mg tablets present an one-